Literature DB >> 7568080

Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.

T S Schaefer1, L K Sanders, D Nathans.   

Abstract

To identify proteins that regulate the transcriptional activity of c-Jun, we have used the yeast two-hybrid screen to detect mammalian polypeptides that might interact functionally with the N-terminal segment of c-Jun, a known regulatory region. Among the proteins identified is a short form of Stat3 (designated Stat3 beta). Stat3 beta is missing the 55 C-terminal amino acid residues of the long form (Stat3 alpha) and has 7 additional amino acid residues at its C terminus. In the absence of added cytokines, expression of Stat3 beta (but not Stat3 alpha) in transfected cells activated a promoter containing the interleukin 6 responsive element of the rat alpha 2-macroglobulin gene; coexpression of Stat3 beta and c-Jun led to enhanced cooperative activation of the promoter. Nuclear extracts of cells transfected with a Stat3 beta expression plasmid formed a complex with an oligonucleotide containing a Stat3 binding site, whereas extracts of cells transfected with a Stat3 alpha plasmid did not. We conclude that there is a short form of Stat3 (Stat3 beta), that Stat3 beta is transcriptionally active under conditions where Stat3 alpha is not, and that Stat3 beta and c-Jun are capable of cooperative activation of certain promoters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568080      PMCID: PMC40931          DOI: 10.1073/pnas.92.20.9097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains.

Authors:  X Y Fu; D S Kessler; S A Veals; D E Levy; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Both Jun and Fos contribute to transcription activation by the heterodimer.

Authors:  S Hirai; B Bourachot; M Yaniv
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

3.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun.

Authors:  V R Baichwal; R Tjian
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

4.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

5.  Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun.

Authors:  D Bohmann; R Tjian
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

6.  Identification of the promoter sequences involved in the interleukin-6 dependent expression of the rat alpha 2-macroglobulin gene.

Authors:  D Kunz; R Zimmermann; M Heisig; P C Heinrich
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

7.  A gene activated by growth factors is related to the oncogene v-jun.

Authors:  K Ryder; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

9.  The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.

Authors:  B J Wagner; T E Hayes; C J Hoban; B H Cochran
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  jun-D: a third member of the jun gene family.

Authors:  K Ryder; A Lanahan; E Perez-Albuerne; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  97 in total

1.  The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.

Authors:  H Chen; J M Lee; Y Wang; D P Huang; R F Ambinder; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Role of the JAK/STAT signal transduction pathway in the regulation of gene expression in CNS.

Authors:  P Dell'Albani; R Santangelo; L Torrisi; V G Nicoletti; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3.

Authors:  Koh Nakayama; Kyung-Woon Kim; Atsushi Miyajima
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

Review 4.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

5.  Negative regulation of STAT92E by an N-terminally truncated STAT protein derived from an alternative promoter site.

Authors:  Melissa A Henriksen; Aurel Betz; Marc V Fuccillo; James E Darnell
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

Review 6.  Three important components in the regeneration of the cavernous nerve: brain-derived neurotrophic factor, vascular endothelial growth factor and the JAK/STAT signaling pathway.

Authors:  Hai-Yang Zhang; Xun-Bo Jin; Tom F Lue
Journal:  Asian J Androl       Date:  2010-12-20       Impact factor: 3.285

Review 7.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

8.  The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.

Authors:  Ravi P Sahu; Sanjay K Srivastava
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

Review 9.  Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Authors:  Zangbéwendé Guy Ouédraogo; Julian Biau; Jean-Louis Kemeny; Laurent Morel; Pierre Verrelle; Emmanuel Chautard
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 10.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.